Catherine E. Lowe

3.7k citations
29 papers · 2.6k · 6 hit papers · h-index 18

Impact in

Papers in

    • Hepatitis C virus research 4
    • Liver Disease Diagnosis and Treatment 3
    • Pneumonia and Respiratory Infections 2
    • Hepatitis B Virus Studies 2

Catherine E. Lowe

28 papers receiving 2.5k citations

Catherine E. Lowe's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+1+3Years since publication100200300400

Peers

Catherine E. Lowe
Comparison fields: 5 of 117
  • Infectious Diseases 988
  • Applied Microbiology and Biotechnology 50
  • Neurology 369
  • Critical Care and Intensive Care Medicine 110
  • Internal Medicine 58
Replace Jordi Margalef with:
Jordi Margalef United Kingdom
Ben Gibbison United Kingdom
Susanne Cathcart United Kingdom
Denise Donaldson United Kingdom
Anne Hayes United Kingdom
A. M. Davison United Kingdom
Jayne Foot Australia
Heather D. Lafferty United Kingdom
Parminder K. Judge United Kingdom
Charlie Harper United Kingdom
Catherine E. Lowe relative to Jordi Margalef United Kingdom Jordi Margalef's profile →
Citations per field
00.5×10×20×33×
Jordi Margalef · 1×
Citations per year

Countries citing papers authored by Catherine E. Lowe

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Lowe more than expected).

Fields of papers citing papers by Catherine E. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Lowe. The network helps show where Catherine E. Lowe may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine E. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine E. Lowe Line = papers co-authored together Catherine E. Lowe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
3 2012325
4
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
5
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
Hit paper breakdown →
2022250
6
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
7
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
8 2006114
9 202383
10 200063
11 196247
12 200446
13 201741
14 200429
15 202024
16 202324
17 202423
18 202118
19 20178
20 20207

About Catherine E. Lowe

Catherine E. Lowe is a scholar working on Hepatology, Epidemiology, Nephrology, Infectious Diseases and Oncology, having authored 29 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Pneumonia and Respiratory Infections (2 papers), Bone health and treatments (2 papers), Hepatitis B Virus Studies (2 papers), Tryptophan and brain disorders (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Infectious Diseases (988 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (369 citations), Critical Care and Intensive Care Medicine (110 citations) and Internal Medicine (58 citations). Catherine E. Lowe has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mary Beth DeYoung, David G. Parkes, Stephen J. Vanner, Dilip Patel, Navaaz A. Saloojee, Alaa Rostom, Catherine E. Dube, Emilie Jolicoeur, Sylvie Grégoire and William C. Thomas. Their work appears in journals such as The Lancet, Vaccine, Neurogastroenterology & Motility, The Journal of Clinical Endocrinology & Metabolism and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact